Patient safety
interpretations of the medical imaging included on a patient’s record.
Combining local hospital data with registry
data provides a deeper understanding of patients’ medical history, enabling MedTech manufacturers to tailor products more closely to specific patients’ needs. And if there’s an incomplete medical history, it’s possible to collect data prospectively, from patient questionnaires or additional clinical assessments. With richer data, manufacturers can gain insights into the outcomes of procedures using their products, and whether there are any links to other medical conditions or circumstances affecting the patient. Most importantly, this model of data sharing has benefits for healthcare as a whole.
The benefits of unlocking health data When manufacturers have access to better quality information about how their products are performing, they can focus their product development on devices which will improve patient outcomes. The provision of anonymised registry data
to the MedTech sector gives manufacturers an improved understanding of the risks and benefits of specific treatments, and what works best for different categories of patient need. Should any issues arise, registry data can also be used to identify patients for recall so that
adverse effects can be mitigated. It’s another step towards meeting the recommendations in the Cumberlege Review12
aimed at avoiding
patient harm caused by medical treatments and devices. As Elaine Young, Director of Operations at the
NJR explains, “There are huge benefits to the medical device industry of having a single, reliable source of data on every patient who has had a joint replacement. This is valuable for certification and post-market surveillance, but also to have feedback on specific cohorts of patients.” With better access to information about patients’ quality of life post-treatment, manufacturers can feed reliable, evidence- based knowledge into the design and development of new medical devices and implants.
Insight for public health Medical device manufacturers need to keep on innovating so they can meet the changing needs of patients. Registry data gives a big picture view of market trends, patient demographics and treatment patterns. This knowledge allows manufacturers to identify patient needs and decide on new areas to target. Manufacturers can also use this public health knowledge to guide their research and development to meet the future needs of patients, and to tackle public health challenges such as healthcare inequalities. This might involve investigating patterns
When manufacturers have access to better quality information about how their products are performing, they can focus their product development on devices which will improve patient outcomes.
42
www.clinicalservicesjournal.com I November 2025
which occur in data on specific groups to answer questions such as – are some subgroups of patients having more success with a procedure than others, and why? Ultimately, opening up access to anonymised
data from registries means that data can be used to train increasingly sophisticated AI models to tackle today’s healthcare challenges. As Emin Aghayev, Senior Advisor for SpineTango13
explains.
“Registry data has a contribution to make to wider research on disease management. This will prove enormously useful, not only for healthcare providers, manufacturers and researchers, but also for policy makers planning healthcare provision on a national scale.” With an ageing population experiencing multiple health conditions,14
the role of data
and the insight it provides will become ever more important. Registry data will become instrumental in joining up information on all the operations and procedures a patient has undergone, not just those in one specialism. This will provide a clearer view of patient comorbidities, which helps in planning treatments more effectively. It can also help manufacturers design products for patients with multiple, complex conditions. Comprehensive registry data on larger cohorts of patients could also reveal previously undiscovered links between the type of diseases patients have, and the conditions they are likely to suffer from in the future. Having a reliable source of data on the health
of the nation gives a wider context on individuals within a population, and the population as a whole, on which to base product development. Now we have the mechanism to share health data more effectively and securely through health data partnerships, manufacturers in the MedTech sector have the real-world evidence on the safety and effectiveness of the devices they provide.
Kirsten Davis/
peopleimages.com -
stock.adobe.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64
